References
- Quigley EM, DiBaise JK. Non-erosive reflux disease: the real problem in gastro-oesophageal reflux disease. Dig Liver Dis 2001;33:523–7.
- Zerbib F, Roman S, Ropert A, des Varannes SB, Pouderoux P, Chaput U, Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006;101:1956–63.
- Bredenoord AJ, Weusten BL, Timmer R, Conchillo JM, Smout AJ. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol 2006;101:453–9.
- Caviglia R, Ribolsi M, Gentile M, Rabitti C, Emerenziani S, Guarino MP, Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007;25:629–36.
- Barlow WJ, Orlando RC. The pathogenesis of heartburn in non-erosive reflux disease: a unifying hypothesis. Gastroenterology 2005;128:771–8.
- Farré R, Fornari F, Blondeau K, Vieth M, De Vos R, Bisschops R, Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut 2010;59:164–9.
- Farré R, van Malenstein H, De Vos R, Geboes K, Depoortere I, Vanden Berghe P, Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut 2008;57:1366–74.
- Bredenoord AJ, Weusten BL, Curvers WL, Timmer R, Smout AJ. Determinants of perception of heartburn and regurgitation. Gut 2006;55:313–18.
- Cicala M, Habib FI, Emerenziani S. Proximal oesophagus: the added value in understanding GORD symptoms. Neurogastroenterol Motil 2009;21:790–5.
- Farré R, Blondeau K, Clement D, Vicario M, Cardozo L, Vieth M, Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut 2011;60:885–92.
- Kessing BF, Bredenoord AJ, Weijenborg PW, Hemmink GJ, Loots CM, Smout AJ. Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol 2011;106:2093–7.
- Fornari F, Blondeau K, Durand L, Rey E, Diaz-Rubio M, De Meyer A, Relevance of mild ineffective oesophageal motility (IOM) and potential pharmacological reversibility of severe IOM in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007;26:1345–54.
- Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96:52–7.
- Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ. The symptom-association probability: an improved method for symptom analysis of 24-h esophageal pH data. Gastroenterology 1994;1071:1741–5.
- Ribolsi M, Emerenziani S, Petitti T, Addarii MC, Balestrieri P, Cicala M. Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responder to proton pump inhibitors. Dig Liver Dis 2012;44:549–54.
- Vela MF, Craft BM, Sharma N, Freeman J, Hazen-Martin D. Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn. Am J Gastroenterol 2011;106:844–50.
- Calabrese C, Fabbri A, Bortolotti M, Cenacchi G, Areni A, Scialpi C, Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux. Aliment Pharmacol Ther 2003;18:525–32.